StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
42
This year
5
Publishing Date
2024 - 03 - 15
1
2024 - 02 - 22
1
2024 - 02 - 14
1
2024 - 02 - 12
1
2024 - 02 - 06
1
2023 - 12 - 08
1
2023 - 11 - 02
1
2023 - 07 - 20
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 15
1
2023 - 04 - 27
1
2023 - 04 - 18
1
2023 - 04 - 04
1
2023 - 03 - 06
1
2023 - 01 - 23
1
2023 - 01 - 19
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 12
1
2022 - 11 - 10
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 06 - 23
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 17
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 01 - 07
1
2021 - 11 - 12
1
2021 - 10 - 04
1
2021 - 08 - 25
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
Sector
Health technology
42
Manufacturing
12
N/a
2
Process industries
1
Professional, scientific, and technical services
2
Tags
Alzheimer's
1
Alzheimer’s
1
Antibody
2
Biopharma
1
Biotech
2
Blood
1
Business
2
Cancer
7
Cell
1
China
3
Clinical-trials-phase-iii
1
Companies
1
Depression
2
Designation
1
Diagnostics
1
Disease
6
Drug
2
Earnings
1
Expansion
1
Expected
2
Financial
1
Gene therapies
1
Gene therapy
1
Global
12
Growing
2
Growth
9
Hormone
1
Iot
2
Lancet
1
License
1
Life
1
Liver
1
Lung
1
Market
26
Metabolic
1
N/a
39
Pharm-country
1
Protein
1
Publication
1
Reach
2
Report
14
Research
5
Results
2
Study
1
System
1
T-cell
1
Technology
2
Therapeutics
6
Therapy
4
Treat
1
Treatment
10
Trial
1
Ulcerative colitis
1
Vaccine
1
Entities
Abbott laboratories
56
Abbvie inc.
111
Abcellera biologics inc
12
Ac immune sa
35
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Akouos, inc.
11
Alnylam pharmaceuticals, inc.
38
Amgen inc.
88
Astellas pharma inc
25
Astrazeneca plc
98
Aveo pharmaceuticals, inc.
25
Baxter international inc.
14
Becton, dickinson and company
21
Beigene, ltd.
19
Biocryst pharmaceuticals, inc.
13
Biogen inc.
20
Biontech se
14
Blueprint medicines corporation
20
Boston scientific corporation
10
Bristol-myers squibb company
106
Clovis oncology, inc.
20
Eli lilly and company
1709
Epizyme, inc.
20
Exelixis, inc.
13
Gilead sciences, inc.
35
Glaxosmithkline plc
107
Hutchison china meditech limited
11
Icon plc
10
Illumina, inc.
15
Incyte corporation
207
Insulet corporation
14
Johnson & johnson
175
Karyopharm therapeutics inc.
20
Ligand pharmaceuticals incorporated
10
Medtronic plc
14
Merus n.v.
21
Nektar therapeutics
10
Novartis ag
138
Novo nordisk a/s
83
Omeros corporation
15
Otonomy, inc.
13
Pfizer, inc.
80
Point biopharma global inc
10
Precision biosciences, inc.
11
Proqr therapeutics n.v.
17
Regeneron pharmaceuticals, inc.
36
Rigel pharmaceuticals, inc.
41
Sanofi
335
Takeda pharmaceutical company limited
42
Terumo corp
14
Teva pharmaceutical industries ltd
61
Thermo fisher scientific inc
14
Ucb s.a.
11
United therapeutics corporation
14
Verastem, inc.
11
Vertex pharmaceuticals incorporated
12
Veru inc.
57
Viatris inc.
18
Y-mabs therapeutics, inc.
18
Symbols
ABBV
31
ABT
10
ADMA
4
ALPMF
12
ALPMY
12
AMGN
23
ARCT
26
ARWR
12
AZN
29
AZNCF
27
BAX
5
BHC
7
BIIB
6
BMY
43
CDXS
3
CMXHF
4
CNTG
5
CSLLY
4
CTLT
3
EXEL
27
FNCTF
4
GBT
3
GILD
15
GLAXF
29
GMAB
3
GRFS
6
GSK
34
HCM
7
INCY
16
JAZZ
6
JNJ
82
KPTI
7
LLY
42
LOGC
4
MGNX
4
MNK
4
MNKKQ
4
MNKPF
4
MOR
13
MPSYF
11
MRNA
5
NBIX
9
NVAX
4
NVO
15
NVS
58
NVSEF
51
OVID
6
PFE
23
REGN
6
SNY
60
SNYNF
51
TAK
421
TEVA
5
TEVJF
20
TMO
7
UCBJF
8
UCBJY
8
VRTX
4
VTRS
7
XNCR
12
Exchanges
Nasdaq
39
Nyse
42
Crawled Date
2024 - 03 - 15
1
2024 - 02 - 22
1
2024 - 02 - 14
1
2024 - 02 - 12
1
2024 - 02 - 07
1
2023 - 12 - 08
1
2023 - 11 - 02
1
2023 - 07 - 20
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 15
1
2023 - 04 - 28
1
2023 - 04 - 18
1
2023 - 04 - 04
1
2023 - 03 - 06
1
2023 - 01 - 23
1
2023 - 01 - 19
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 12
1
2022 - 11 - 10
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 06 - 23
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 17
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 01 - 07
1
2021 - 11 - 12
1
2021 - 10 - 04
1
2021 - 08 - 25
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
Crawled Time
00:00
3
01:00
4
02:00
3
04:00
1
08:00
2
10:00
5
11:00
2
12:00
1
13:00
3
13:20
1
14:00
1
14:30
1
15:15
1
15:20
1
16:00
1
17:00
1
18:00
1
19:00
3
20:00
2
21:00
2
22:00
1
23:00
2
Source
www.biospace.com
3
www.globenewswire.com
2
www.prnewswire.com
37
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Takeda pharmaceutical company limited
symbols :
Lly
save search
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.15%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.85%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.31%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.4%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.03%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.03%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.43%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
12.7%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
15.41%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-1.04%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.08%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
0.2%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.33%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.49%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.095
0.64%
0.64%
87K
|
Health Technology
|
-25.19%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.93%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.95%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.09%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-22.28%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-23.82%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.61%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
28.63%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.97%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.07%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
27.99%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.71%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
11.75%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.46%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.29%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.35%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
Published:
2023-11-02
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-3.66%
|
O:
1.03%
H:
0.73%
C:
0.58%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
35.86%
|
O:
4.42%
H:
0.0%
C:
0.0%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
financial
results
HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study
Published:
2023-07-20
(Crawled : 00:00)
- globenewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-14.83%
|
O:
-0.65%
H:
0.49%
C:
0.07%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.53%
|
O:
0.35%
H:
2.21%
C:
1.9%
HCM
|
$16.49
0.8%
0.79%
61K
|
Health Technology
|
34.84%
|
O:
-0.33%
H:
2.55%
C:
1.4%
treatment
designation
china
therapy
study
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.61%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-31.09%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.46%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-11.42%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.18%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.82%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.45%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.83%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet
Published:
2023-06-16
(Crawled : 10:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.58%
|
O:
-0.06%
H:
0.53%
C:
-0.31%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.39%
|
O:
0.41%
H:
0.26%
C:
-1.77%
lancet
publication
results
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-7.89%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.27%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.5%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.25%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
72.05%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.87%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-21.24%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.88%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
19.74%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published:
2023-05-15
(Crawled : 10:00)
- prnewswire.com
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
38.83%
|
O:
1.79%
H:
0.18%
C:
-0.06%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-19.72%
|
O:
0.61%
H:
0.3%
C:
0.24%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.85%
|
O:
0.01%
H:
0.14%
C:
-0.78%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
72.82%
|
O:
0.22%
H:
0.14%
C:
-0.2%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.24%
|
O:
0.35%
H:
0.83%
C:
-0.73%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
13.69%
|
O:
0.17%
H:
1.07%
C:
0.19%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.86%
|
O:
0.38%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.42%
|
O:
-0.13%
H:
0.42%
C:
0.4%
research
global
growth
market
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published:
2023-04-27
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.12%
|
O:
0.23%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-22.0%
|
O:
-1.13%
H:
0.3%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.32%
|
O:
-0.79%
H:
0.89%
C:
0.72%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-11.07%
|
O:
-0.12%
H:
0.58%
C:
0.55%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.97%
|
O:
-0.25%
H:
0.97%
C:
0.31%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
92.33%
|
O:
1.96%
H:
1.59%
C:
-0.54%
drug
report
treatment
global
growing
market
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
Published:
2023-04-18
(Crawled : 01:00)
- globenewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-21.16%
|
O:
0.9%
H:
0.0%
C:
-0.71%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
101.63%
|
O:
0.17%
H:
0.34%
C:
-0.83%
HCM
|
$16.49
0.8%
0.79%
61K
|
Health Technology
|
-2.08%
|
O:
1.49%
H:
2.64%
C:
1.52%
china
Global Depression Treatment Market to 2030: Rising Prevalence of Psychiatric Diseases and Development of Innovative Medications for Treatment-resistant Depression Drives Growth
Published:
2023-04-04
(Crawled : 02:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-20.4%
|
O:
-0.12%
H:
1.55%
C:
1.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
114.05%
|
O:
0.38%
H:
1.97%
C:
0.72%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-30.69%
|
O:
0.13%
H:
0.0%
C:
-1.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.36%
|
O:
-0.1%
H:
0.0%
C:
0.0%
depression
treatment
global
growth
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-10.86%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
-11.33%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.92%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-4.57%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
33.0%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-15.92%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-18.72%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.95%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
135.38%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.48
-0.57%
-0.4%
1.6M
|
Health Technology
|
-21.81%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-29.9%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
$112.15
0.31%
-0.13%
2M
|
Process Industries
|
-55.43%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
6.36%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.65%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-17.52%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-27.79%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.74%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
Published:
2023-01-23
(Crawled : 10:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-19.18%
|
O:
-0.25%
H:
0.4%
C:
-0.25%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
116.94%
|
O:
0.16%
H:
0.0%
C:
-1.27%
license
china
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.14%
|
O:
0.69%
H:
0.0%
C:
-1.52%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.53%
|
O:
-0.31%
H:
1.15%
C:
0.68%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-10.9%
|
O:
0.13%
H:
0.65%
C:
0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.61%
|
O:
-0.43%
H:
1.33%
C:
0.3%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.53%
|
O:
0.17%
H:
1.36%
C:
1.02%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
113.28%
|
O:
0.1%
H:
0.97%
C:
-0.37%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.05%
|
O:
0.29%
H:
2.1%
C:
1.94%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
10.7%
|
O:
-0.17%
H:
1.07%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.54%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.11%
|
O:
0.51%
H:
0.49%
C:
-0.65%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
0.21%
|
O:
-0.9%
H:
0.58%
C:
0.01%
global
report
growth
market
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published:
2023-01-18
(Crawled : 12:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-94.91%
|
O:
-0.13%
H:
3.25%
C:
-3.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.58%
|
O:
0.62%
H:
0.12%
C:
-0.68%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-44.84%
|
O:
-1.16%
H:
0.67%
C:
-1.2%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-15.9%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.86%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
-27.97%
|
O:
0.07%
H:
2.69%
C:
0.32%
market
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.